- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Muscle Invasive Bladder Neoplasms in United Kingdom
Total 7456 results
-
Nucleix Ltd.CompletedNon Muscle Invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
University College, LondonAstraZeneca; ShionogiRecruitingBladder CancerUnited Kingdom
-
ViralyticsCompletedNon-muscle Invasive Bladder CancerUnited Kingdom
-
VA Office of Research and DevelopmentUniversity of California, DavisRecruiting
-
University of Texas Southwestern Medical CenterRecruitingNon-muscle-invasive Bladder CancerUnited States
-
ImmunityBio, Inc.Active, not recruitingNon Muscle Invasive Bladder CancerUnited States
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
Johns Hopkins UniversityRecruitingNon-Muscle Invasive Bladder CancerUnited States
-
University of VirginiaAmerican Cancer Society, Inc.; Integrated Translational Health Research Institute...RecruitingBladder Cancer | Muscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerUnited States, Israel
-
AstraZenecaParexelRecruitingNon-Muscle- Invasive Bladder CancerUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
Fox Chase Cancer CenterJanssen PharmaceuticalsNot yet recruitingUrothelial Carcinoma | Non-Muscle Invasive Bladder Urothelial Carcinoma | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom
-
enGene, Inc.RecruitingSuperficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in SituUnited States
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
University of OxfordMerck Sharp & Dohme LLCTerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United Kingdom
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedUrinary Bladder NeoplasmsUnited States
-
CepheidAxonal-Biostatem; Stève ConsultantsCompletedNon-muscle-invasive Bladder CancerUnited Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingBladder Cancer | NMIBC | Urothelial Carcinoma Recurrent | Non-Muscle Invasive Bladder CancerUnited States
-
University of OklahomaEMD SeronoCompletedBladder CancerUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Netherlands, Portugal, Australia, Russian Federation, Ukraine
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Ferring PharmaceuticalsFKD Therapies Oy; Society of Urologic Oncology Clinical Trials ConsortiumCompletedSuperficial Bladder CancerUnited States
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Ukraine
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Moldova, Republic of, Romania, Ukraine
-
Mayo ClinicRecruitingNon-muscle Invasive Bladder Cancer | Stage 0a Bladder Cancer AJCC v8 | NMIBCUnited States
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
Rapamycin Holdings, Inc. dba Emtora BiosciencesNational Cancer Institute (NCI)RecruitingNon-muscle Invasive Bladder CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
ImmunityBio, Inc.Active, not recruiting
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom